JPMorgan Chase & Co’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,111
| Closed | -$1.47K | – | 6681 |
|
2024
Q3 | $1.47K | Buy |
1,111
+107
| +11% | +$141 | ﹤0.01% | 5606 |
|
2024
Q2 | $7.63K | Hold |
1,004
| – | – | ﹤0.01% | 5300 |
|
2024
Q1 | $9.04K | Hold |
1,004
| – | – | ﹤0.01% | 5352 |
|
2023
Q4 | $10.8K | Hold |
1,004
| – | – | ﹤0.01% | 5365 |
|
2023
Q3 | $6.09K | Buy |
1,004
+1,003
| +100,300% | +$6.09K | ﹤0.01% | 5398 |
|
2023
Q2 | $9 | Hold |
1
| – | – | ﹤0.01% | 5915 |
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6232 |
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6079 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5940 |
|
2022
Q2 | $0 | Sell |
1
-1,038
| -100% | – | ﹤0.01% | 6024 |
|
2022
Q1 | $29K | Sell |
1,039
-15
| -1% | -$419 | ﹤0.01% | 5189 |
|
2021
Q4 | $48K | Sell |
1,054
-996
| -49% | -$45.4K | ﹤0.01% | 5091 |
|
2021
Q3 | $171K | Buy |
2,050
+1,200
| +141% | +$100K | ﹤0.01% | 4484 |
|
2021
Q2 | $81K | Buy |
850
+838
| +6,983% | +$79.9K | ﹤0.01% | 4831 |
|
2021
Q1 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 5175 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5167 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 5088 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 5019 |
|
2019
Q4 | – | Sell |
-3
| Closed | – | – | 4916 |
|
2019
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4951 |
|
2019
Q2 | – | Sell |
-9
| Closed | -$1K | – | 4985 |
|
2019
Q1 | $1K | Sell |
9
-41
| -82% | -$4.56K | ﹤0.01% | 4795 |
|
2018
Q4 | $5K | Buy |
50
+42
| +525% | +$4.2K | ﹤0.01% | 4712 |
|
2018
Q3 | $2K | Sell |
8
-30
| -79% | -$7.5K | ﹤0.01% | 4767 |
|
2018
Q2 | $82K | Buy |
+38
| New | +$82K | ﹤0.01% | 4148 |
|
2018
Q1 | – | Sell |
-7
| Closed | -$12K | – | 4818 |
|
2017
Q4 | $12K | Sell |
7
-22
| -76% | -$37.7K | ﹤0.01% | 4474 |
|
2017
Q3 | $35K | Buy |
+29
| New | +$35K | ﹤0.01% | 3875 |
|